Amplia Therapeutics Announces Trading Halt for Capital Raising
Key points
- Amplia Therapeutics requests trading halt to undertake a share placement and share purchase plan
- Trading halt to remain in place until announcement of the Offer outcome or market open on July 23
- Offer is to be undertaken in an orderly manner
Full summary
Amplia Therapeutics Limited (ASX: ATX) has requested an immediate trading halt on its securities, pending an announcement regarding a capital raising to be undertaken by way of a share placement and share purchase plan (the Offer). The trading halt is required to enable the Offer to be undertaken in an orderly manner. Amplia has requested that the trading halt remain in place until the earlier of such time as it makes an announcement to the market in relation to the outcome of the Offer and the commencement of trading on Wednesday, 23 July 2025. Amplia is not aware of any reason why the trading halt should not be granted or of any other information necessary to inform the market or ASX about the trading halt. The capital raising is expected to strengthen Amplia's financial position as it continues to advance its pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis.
Summary generated by a large language model. Please interpret with care.